Member Info for oldstockbroker

I am assuming the sales were purchased by the company-i think price was in range for buy back. That will incease NAV for shareholders.

I have total confidence in this company. I have researched as best I can, and downside is limited unless the Gold Price goes sub $1200. Good management who seem honest and not puffing the stock-listen to the presentation-they just tell the facts.

MPO Results will be releases on 23rd Septemder 2013.

Done a Q&D on possible NVA. 60% of PEBI is in quoted stocks, Two-PLE an SUMM are up 100% since last NAV announced-that was 11.2p So assuming balanced portolio, and allowing for some not performing as well I see an uplift on the quoted portfolio of 55%-say now 11p. Unquoted probably up 30%- say 6p. That gives me a worse case of 17p NAV. Could be more as I have been very conservative in my calculations. If all quoted have doubled, then we are looking at a potential NAV of 19.5p. And some of the unquoted may have risen in value more, but no idea on that. As all of said an interesting Bio-Tech play, and as the only other quoted IT I could find is trading at Par to NAV cannot quite see why this is it such a discount. I assume due to size the institutions are not in. This is my research, so do your own and do not rely on me in making an investment choice please.

http://www.trustnet.com/Factsheets/Factsheet.aspx?fundCode=AKFR0&univ=T Similar fund.

Discount to Nav Apologies- " discount no NAV."

Looks ok to me. I get some wrong .Most fund manager's are happy wiith 55%.(Rises v. fallers) Many fail to achieve this. Investing is risky, but in this case I am pretty relaxed. The market does not seem to understand these fund performance. Used to mainly deal in Investment Trusts as a young broker before I moved on to smaller companies. In those days they traded at a huge discount no NAV. Now IT are trading at at low discount or even premium to NAV. Why Pebi and MPO are trading at a discount is beyond me

Missed that on my research-thanks. I bought in low following article about PLE. Was happy to find a fund that had PLE and other interesting investments.

Checked out Libra-they are not an bear seller. It is part of a wind-up of the fund as they reduce operations, but as I gather no rush. So Ok a bit of an overhang, but they are disposing of their entire portfolio, not just Amara, in an orderly fashion. Wish I had the cash to bid low for the stake!

Read the posts below to see how. Next NAV from company will be announced end sept/beginning oct.

Tend to agree undervalued. The US Biotech index over the last 6 months has risen from 950 to 1250 and PLE etc have risen .

Both !!! Was in the City in the 1970's-80's.

Same with me-I have another 12 stocks in portfolio.

Thanks-still going through it. I think they are planning to scale back Baomahun slightly to retain 100%. Looks like Sega cash flow will fund it then and retain 100% ownership. I believe the makeket expected a farm out deal, but listening to audio presentation I think Amara want to become a serious producer rather than an explorer. But that is just my view, but Baomahun and Yaoure seem to have huge potential for the future.Early day's but looks like has good potential.

Bought in a couple of month's ago. Looks interesting, just wish company were more forthcoming. But had a good return so far and will let it run. I suspect next NAV will be up, but just guessing.

That was Director's salaries. Apologies error.

No panic. Suggest you look at the figures and listen to the presentation. Amara has cash in the bank, sold gold post year-end to add another $9.8 m cash to balance sheet(valued at $9.0 m at year end). As i recall in presentation potential gold assets at current share price valued at $10 per oz. Normal majors at $23 and Juniors at $45. So Amara well undervalued. Libra selling is an irrelavance in my opinion, we have no idea what their views are. Amara has good cash flow for the next 13 months and then the Baomahun and Yaoure will be on stream. But not too bothered about short term moves, in here for the long term and have total faith in management-if they thought was failing would have hardly cut salaries by 12.5% and introduced cost cutting measures, which have support of staff and workers. Looks a pretty well managed business to me, where all believe in the future. Speak to them, they are very approachable and respond. Hence the reason I have a large holding as a % of my portfolio. But do your own research as always.

Thanks-not a subscriber to IC so missed that. At least we agree on a target price of £2.20, but obvioulsy have not seen his rationale.

There has been reasonable buying over the last few days. Not sure where it is coming from. I am begginning to think that there maybe Far East buying, which would suggest my NAV target may be low. Time will tell. The news from Macao is all good in terms of Tourism/Gambling, so very happy to be in this one.

From accounts "Final dividend of 3.0 pence per share recommended, making a total distribution of 7. 8 pence for the year (2011: 5.0 pence)."